http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24924826
Outgoing Links
Predicate
Object
contentType
Clinical Trial, Phase II|Journal Article
endingPage
4
issn
2542-5641
issueIdentifier
18
pageRange
3470-4
publicationName
Chinese medical journal
startingPage
3470
bibliographicCitation
Yang L, Song Y, Zhou AP, Qin Q, Chi Y, Huang J, Wang JW. A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer. Chin Med J (Engl). 2013;126(18):3470–4. PMID: 24034092.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05110da2b46d93d6f636169e4d709060
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56ac7426807dde37f0c9b450e103c86a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd902c46cc3c073a8277be39d35a9831
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f7c5b226153cd1b0ec009dc348d5c73
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dec7e629a7ea2a17bfff872b02907c27
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7102b390210b1903e78e371e2b2bb34e
date
2013
identifier
https://pubmed.ncbi.nlm.nih.gov/24034092
isPartOf
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2927
https://portal.issn.org/resource/ISSN/2542-5641
language
English
source
https://pubmed.ncbi.nlm.nih.gov/
title
A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
discusses
http://id.nlm.nih.gov/mesh/M0095550
http://id.nlm.nih.gov/mesh/M0015422
http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm
http://id.nlm.nih.gov/mesh/D013274Q000188
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D009944Q000627
hasSubjectTerm
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000077150
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887053
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
Total number of triples:
42
.